Guggenheim Capital LLC Staar Surgical CO Transaction History

Guggenheim Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$70.55 - $111.58 $73,513 - $116,266	-1,042 Reduced 13.01%	6,969 $492,000
Q2 2022 Aug 15, 2022	SELL	$50.24 - $80.48 $30,294 - $48,529	-603 Reduced 7.0%	8,011 $568,000
Q1 2022 May 16, 2022	SELL	$57.98 - $93.5 $113,292 - $182,699	-1,954 Reduced 18.49%	8,614 $688,000
Q4 2021 Feb 14, 2022	SELL	$88.02 - $127.79 $921,305 - $1.34 Million	-10,467 Reduced 49.76%	10,568 $965,000
Q3 2021 Nov 15, 2021	SELL	$122.75 - $162.68 $75,123 - $99,560	-612 Reduced 2.83%	21,035 $2.7 Million
Q2 2021 Aug 13, 2021	BUY	$105.76 - $154.96 $240,180 - $351,914	2,271 Added 11.72%	21,647 $3.3 Million
Q1 2021 May 13, 2021	BUY	$78.5 - $126.48 $1.52 Million - $2.45 Million	19,376 New	19,376 $2.04 Million

233

47.7M

98.6K

180K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $854M
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.